Adenylate kinase 3 sensitizes cells to cigarette smoke condensate vapor induced cisplatin resistance

PLoS ONE

Volumn 6, Issue 6, 2011, Pages

  Chang, Xiaofei ^a   Ravi, Rajani ^a   Pham, Vui ^a   Bedi, Atul ^a   Chatterjee, Aditi ^a   Sidransky, David ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE KINASE; ADENYLATE KINASE 3; BETA ACTIN; CIGARETTE SMOKE CONDENSATE; CISPLATIN; LACTATE DEHYDROGENASE; MITOCHONDRIAL PROTEIN; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL XL; REACTIVE OXYGEN METABOLITE; TOBACCO SMOKE; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BLADDER CANCER; CANCER CELL CULTURE; CANCER CHEMOTHERAPY; CANCER RESISTANCE; CHEMOSENSITIVITY; CHEMOSENSITIZATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DRUG CYTOTOXICITY; DRUG EFFECT; ENZYME RELEASE; FEMALE; HUMAN; HUMAN CELL; LONG TERM EXPOSURE; MITOCHONDRIAL MEMBRANE POTENTIAL; MOUSE; NONHUMAN; PROTEIN EXPRESSION; TUMOR GROWTH; VAPOR; CELL LINE; DRUG RESISTANCE; METABOLISM; SMOKE; TOBACCO;

ADENYLATE KINASE; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL LINE; CISPLATIN; DRUG RESISTANCE, NEOPLASM; SMOKE; TOBACCO;

EID: 79958787979     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0020806     Document Type: Article

References (58)

1. Jankovic S, Radosavljevic V, (2007) Risk factors for bladder cancer. Tumori 93: 4-12.
2. Hecht SS, (2002) Tobacco smoke carcinogens and breast cancer. Environ Mol Mutagen 39: 119-126.
3. Skipper PL, Tannenbaum SR, Ross RK, Yu MC, (2003) Nonsmoking-related arylamine exposure and bladder cancer risk. Cancer Epidemiol Biomarkers Prev 12: 503-507.
4. Boffetta P, (2004) Epidemiology of environmental and occupational cancer. Oncogene 23: 6392-6403.
5. Barsanti KC, Luo W, Isabelle LM, Pankow JF, Peyton DH, (2007) Tobacco smoke particulate matter chemistry by NMR. Magn Reson Chem 45: 167-170.
6. Hecht SS, (2002) Human urinary carcinogen metabolites: biomarkers for investigating tobacco and cancer. Carcinogenesis 23: 907-922.
7. Fagerstrom K, (2002) The epidemiology of smoking: health consequences and benefits of cessation. Drugs 62 (Suppl 2): 1-9.
8. Choi MK, Kim DD, (2006) Platinum transporters and drug resistance. Arch Pharm Res 29: 1067-1073.
9. Browman GP, Wong G, Hodson I, Sathya J, Russell R, et al. (1993) Influence of cigarette smoking on the efficacy of radiation therapy in head and neck cancer. N Engl J Med 328: 159-163.
10. Oh WK, Manola J, Renshaw AA, Brodkin D, Loughlin KR, et al. (2000) Smoking and alcohol use may be risk factors for poorer outcome in patients with clear cell renal carcinoma. Urology 55: 31-35.
11. Fleshner N, Garland J, Moadel A, Herr H, Ostroff J, et al. (1999) Influence of smoking status on the disease-related outcomes of patients with tobacco-associated superficial transitional cell carcinoma of the bladder. Cancer 86: 2337-2345.
12. Marshak G, Brenner B, Shvero J, Shapira J, Ophir D, et al. (1999) Prognostic factors for local control of early glottic cancer: the Rabin Medical Center retrospective study on 207 patients. Int J Radiat Oncol Biol Phys 43: 1009-1013.
13. van der Voet JC, Keus RB, Hart AA, Hilgers FJ, Bartelink H, (1998) The impact of treatment time and smoking on local control and complications in T1 glottic cancer. Int J Radiat Oncol Biol Phys 42: 247-255.
14. Tsai YC, Nichols PW, Hiti AL, Williams Z, Skinner DG, et al. (1990) Allelic losses of chromosomes 9, 11, and 17 in human bladder cancer. Cancer Res 50: 44-47.
15. Williamson MP, Elder PA, Shaw ME, Devlin J, Knowles MA, (1995) p16 (CDKN2) is a major deletion target at 9p21 in bladder cancer. Hum Mol Genet 4: 1569-1577.
16. Blaveri E, Brewer JL, Roydasgupta R, Fridlyand J, DeVries S, et al. (2005) Bladder cancer stage and outcome by array-based comparative genomic hybridization. Clin Cancer Res 11: 7012-7022.
17. Nobumoto M, Yamada M, Song S, Inouye S, Nakazawa A, (1998) Mechanism of mitochondrial import of adenylate kinase isozymes. J Biochem (Tokyo) 123: 128-135.
18. Knight-Lozano CA, Young CG, Burow DL, Hu ZY, Uyeminami D, et al. (2002) Cigarette smoke exposure and hypercholesterolemia increase mitochondrial damage in cardiovascular tissues. Circulation 105: 849-854.
19. Wickenden JA, Clarke MC, Rossi AG, Rahman I, Faux SP, et al. (2003) Cigarette smoke prevents apoptosis through inhibition of caspase activation and induces necrosis. Am J Respir Cell Mol Biol 29: 562-570.
20. Cho HJ, Kim JK, Kim KD, Yoon HK, Cho MY, et al. (2006) Upregulation of Bcl-2 is associated with cisplatin-resistance via inhibition of Bax translocation in human bladder cancer cells. Cancer Lett 237: 56-66.
21. Chang SS, Jiang WW, Smith I, Glazer C, Sun WY,et al. Chronic cigarette smoke extract treatment selects for apoptotic dysfunction and mitochondrial mutations in minimally transformed oral keratinocytes. Int J Cancer 126: 19-27.
22. Jiang X, Yuan JM, Skipper PL, Tannenbaum SR, Yu MC, (2007) Environmental tobacco smoke and bladder cancer risk in never smokers of Los Angeles County. Cancer Res 67: 7540-7545.
23. De Flora S, D'Agostini F, Balansky R, Camoirano A, Cartiglia C, et al. (2008) High susceptibility of neonatal mice to molecular, biochemical and cytogenetic alterations induced by environmental cigarette smoke and light. Mutat Res 659: 137-146.
24. Izzotti A, D'Agostini F, Balansky R, Degan P, Pennisi TM, et al. (2008) Exposure of mice to cigarette smoke and/or light causes DNA alterations in heart and aorta. Mutat Res 644: 38-42.
25. Mattenheimer H, (1975) Ciliotoxicity of cigarette smoke and adenylate kinase. Z Klin Chem Klin Biochem 13: 325-326.
26. Tanabe T, Yamada M, Noma T, Kajii T, Nakazawa A, (1993) Tissue-specific and developmentally regulated expression of the genes encoding adenylate kinase isozymes. J Biochem 113: 200-207.
27. Inouye S, Seo M, Yamada Y, Nakazawa A, (1998) Increase of adenylate kinase isozyme 1 protein during neuronal differentiation in mouse embryonal carcinoma P19 cells and in rat brain primary cultured cells. J Neurochem 71: 125-133.
28. O'Rourke JF, Pugh CW, Bartlett SM, Ratcliffe PJ, (1996) Identification of hypoxically inducible mRNAs in HeLa cells using differential-display PCR. Role of hypoxia-inducible factor-1. Eur J Biochem 241: 403-410.
29. Miro O, Alonso JR, Jarreta D, Casademont J, Urbano-Marquez A, et al. (1999) Smoking disturbs mitochondrial respiratory chain function and enhances lipid peroxidation on human circulating lymphocytes. Carcinogenesis 20: 1331-1336.
30. van der Toorn M, Slebos DJ, de Bruin HG, Leuvenink HG, Bakker SJ, et al. (2007) Cigarette smoke-induced blockade of the mitochondrial respiratory chain switches lung epithelial cell apoptosis into necrosis. Am J Physiol Lung Cell Mol Physiol 292: L1211-1218.
31. Lu X, Cai J, Kong H, Wu M, Hua R, et al. (2003) Analysis of cigarette smoke condensates by comprehensive two-dimensional gas chromatography/time-of-flight mass spectrometry I acidic fraction. Anal Chem 75: 4441-4451.
32. Rustemeier K, Stabbert R, Haussmann HJ, Roemer E, Carmines EL, (2002) Evaluation of the potential effects of ingredients added to cigarettes. Part 2: chemical composition of mainstream smoke. Food Chem Toxicol 40: 93-104.
33. Dzeja PP, Terzic A, (1998) Phosphotransfer reactions in the regulation of ATP-sensitive K+ channels. Faseb J 12: 523-529.
34. Inouye S, Yamada Y, Miura K, Suzuki H, Kawata K, et al. (1999) Distribution and developmental changes of adenylate kinase isozymes in the rat brain: localization of adenylate kinase 1 in the olfactory bulb. Biochem Biophys Res Commun 254: 618-622.
35. Slebos DJ, Ryter SW, van der Toorn M, Liu F, Guo F, et al. (2007) Mitochondrial localization and function of heme oxygenase-1 in cigarette smoke-induced cell death. Am J Respir Cell Mol Biol 36: 409-417.
36. Cullen KJ, Yang Z, Schumaker L, Guo Z, (2007) Mitochondria as a critical target of the chemotheraputic agent cisplatin in head and neck cancer. J Bioenerg Biomembr 39: 43-50.
37. Fuertesa MA, Castillab J, Alonsoa C, Perez JM, (2003) Cisplatin biochemical mechanism of action: from cytotoxicity to induction of cell death through interconnections between apoptotic and necrotic pathways. Curr Med Chem 10: 257-266.
38. Gonzalez VM, Fuertes MA, Alonso C, Perez JM, (2001) Is cisplatin-induced cell death always produced by apoptosis? Mol Pharmacol 59: 657-663.
39. Murata T, Hibasami H, Maekawa S, Tagawa T, Nakashima K, (1990) Preferential binding of cisplatin to mitochondrial DNA and suppression of ATP generation in human malignant melanoma cells. Biochem Int 20: 949-955.
40. Olivero OA, Chang PK, Lopez-Larraza DM, Semino-Mora MC, Poirier MC, (1997) Preferential formation and decreased removal of cisplatin-DNA adducts in Chinese hamster ovary cell mitochondrial DNA as compared to nuclear DNA. Mutat Res 391: 79-86.
41. Yang Z, Faustino PJ, Andrews PA, Monastra R, Rasmussen AA, et al. (2000) Decreased cisplatin/DNA adduct formation is associated with cisplatin resistance in human head and neck cancer cell lines. Cancer Chemother Pharmacol 46: 255-262.
42. Green DR, Reed JC, (1998) Mitochondria and apoptosis. Science 281: 1309-1312.
43. Moodie FM, Marwick JA, Anderson CS, Szulakowski P, Biswas SK, et al. (2004) Oxidative stress and cigarette smoke alter chromatin remodeling but differentially regulate NF-kappaB activation and proinflammatory cytokine release in alveolar epithelial cells. Faseb J 18: 1897-1899.
44. Rahman I, Antonicelli F, MacNee W, (1999) Molecular mechanism of the regulation of glutathione synthesis by tumor necrosis factor-alpha and dexamethasone in human alveolar epithelial cells. J Biol Chem 274: 5088-5096.
45. Ravi R, Bedi A, (2002) Requirement of BAX for TRAIL/Apo2L-induced apoptosis of colorectal cancers: synergism with sulindac-mediated inhibition of Bcl-x(L). Cancer Res 62: 1583-1587.
46. Olopade OI, Adeyanju MO, Safa AR, Hagos F, Mick R, et al. (1997) Overexpression of BCL-x protein in primary breast cancer is associated with high tumor grade and nodal metastases. Cancer J Sci Am 3: 230-237.
47. Cherbonnel-Lasserre C, Gauny S, Kronenberg A, (1996) Suppression of apoptosis by Bcl-2 or Bcl-xL promotes susceptibility to mutagenesis. Oncogene 13: 1489-1497.
48. Cheng EH, Wei MC, Weiler S, Flavell RA, Mak TW, et al. (2001) BCL-2, BCL-X(L) sequester BH3 domain-only molecules preventing BAX- and BAK-mediated mitochondrial apoptosis. Mol Cell 8: 705-711.
49. Kartalou M, Essigmann JM, (2001) Mechanisms of resistance to cisplatin. Mutat Res 478: 23-43.
50. Galluzzi L, Morselli E, Vitale I, Kepp O, Senovilla L, et al. miR-181a and miR-630 regulate cisplatin-induced cancer cell death. Cancer Res 70: 1793-1803.
51. Chatterjee A, Mambo E, Zhang Y, Deweese T, Sidransky D, (2006) Targeting of mutant hogg1 in mammalian mitochondria and nucleus: effect on cellular survival upon oxidative stress. BMC Cancer 6: 235.
52. Yang A, Cardona DL, Barile FA, (2002) In vitro cytotoxicity testing with fluorescence-based assays in cultured human lung and dermal cells. Cell Biol Toxicol 18: 97-108.
53. Mambo E, Nyaga SG, Bohr VA, Evans MK, (2002) Defective repair of 8-hydroxyguanine in mitochondria of MCF-7 and MDA-MB-468 human breast cancer cell lines. Cancer Res 62: 1349-1355.
54. Chatterjee A, Chang X, Nagpal JK, Chang S, Upadhyay S, et al. (2008) Targeting human 8-oxoguanine DNA glycosylase to mitochondria protects cells from 2-methoxyestradiol-induced-mitochondria-dependent apoptosis. Oncogene 27: 3710-3720.
55. Reers M, Smith TW, Chen LB, (1991) J-aggregate formation of a carbocyanine as a quantitative fluorescent indicator of membrane potential. Biochemistry 30: 4480-4486.
56. Salvioli S, Ardizzoni A, Franceschi C, Cossarizza A, (1997) JC-1, but not DiOC6(3) or rhodamine 123, is a reliable fluorescent probe to assess delta psi changes in intact cells: implications for studies on mitochondrial functionality during apoptosis. FEBS Lett 411: 77-82.
57. Smith JA, Weidemann MJ, (1993) Further characterization of the neutrophil oxidative burst by flow cytometry. J Immunol Methods 162: 261-268.
58. Fanizza C, Ursini CL, Paba E, Ciervo A, Di Francesco A, et al. (2007) Cytotoxicity and DNA-damage in human lung epithelial cells exposed to respirable alpha-quartz. Toxicol In Vitro 21: 586-594.